Mankind Pharma Share Price

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It also offers pet care, crop protection solutions, and veterinary care. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/central nervous system, vitamins, minerals and nutrients, derma, fertility, and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.As of 14 Jun 2026, Mankind Pharma share price is ₹2,381.10. The stock opened at ₹2,419.00, compared to its previous close of ₹2,372.70. During today's trading session, Mankind Pharma share price moved in the range of ₹2,368.10 to ₹2,419.00, with an average price of ₹2,393.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,368.10 and a high of ₹2,419.00. On the performance front, Mankind Pharma share price has increased by 9.28% over the last six months and is down 0.37% on a year-on-year basis.

The market capitalization of Mankind Pharma is ₹98,270 Crs, with a P/E ratio of 50.7 and a dividend yield of 0.04%.